Full Year Results 

Mediclinic leverage creeping up

Mediclinic leverage creeping up

Mediclinic International (MDC) recorded a 4 per cent revenue rise at constant currencies for its March year-end and adjusted earnings in line with market expectations at 26.9p a share. But, as was foreshadowed in November’s interim statement, the private hospital/clinic group swung to another statutory loss on an aggregate £405m in impairments on the group’s stake in industry peer Spire Healthcare (SPI) and on Swiss hospital business Hirslanden.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now